SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013192
Filing Date
2022-08-11
Accepted
2022-08-11 08:45:42
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20220630x10q.htm   iXBRL 10-Q 2026818
2 EX-31.1 mgtx-20220630xex31d1.htm EX-31.1 11371
3 EX-31.2 mgtx-20220630xex31d2.htm EX-31.2 11321
4 EX-32.1 mgtx-20220630xex32d1.htm EX-32.1 6762
5 EX-32.2 mgtx-20220630xex32d2.htm EX-32.2 6770
  Complete submission text file 0001558370-22-013192.txt   7378466

Data Files

Seq Description Document Type Size
6 EX-101.SCH mgtx-20220630.xsd EX-101.SCH 48248
7 EX-101.CAL mgtx-20220630_cal.xml EX-101.CAL 53053
8 EX-101.DEF mgtx-20220630_def.xml EX-101.DEF 181059
9 EX-101.LAB mgtx-20220630_lab.xml EX-101.LAB 379946
10 EX-101.PRE mgtx-20220630_pre.xml EX-101.PRE 325773
57 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20220630x10q_htm.xml XML 1291490
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 221153879
SIC: 2836 Biological Products, (No Diagnostic Substances)